Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.
about
Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease.Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.Protective effect and molecular mechanism of liquiritin on oxybuprocaine-induced apoptosis of human corneal endothelial cells.
P2860
Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Fenofibrate, a PPARα agonist, ...... s via the activation of NF-kB.
@ast
Fenofibrate, a PPARα agonist, ...... s via the activation of NF-kB.
@en
type
label
Fenofibrate, a PPARα agonist, ...... s via the activation of NF-kB.
@ast
Fenofibrate, a PPARα agonist, ...... s via the activation of NF-kB.
@en
prefLabel
Fenofibrate, a PPARα agonist, ...... s via the activation of NF-kB.
@ast
Fenofibrate, a PPARα agonist, ...... s via the activation of NF-kB.
@en
P2093
P2860
P1476
Fenofibrate, a PPARα agonist, ...... s via the activation of NF-kB.
@en
P2093
P2860
P304
10653-10661
P577
2015-09-01T00:00:00Z